Cargando…

Lentiviral Mediated ADA2 Gene Transfer Corrects the Defects Associated With Deficiency of Adenosine Deaminase Type 2

Deficiency of adenosine deaminase type 2 (DADA2) is an autosomal recessive disease caused by bi-allelic loss-of-function mutations in ADA2. Treatment with anti-TNF is effective for the autoinflammatory and vasculitic components of the disease but does not correct marrow failure or immunodeficiency;...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Ying, Casimir, Marina, Houghton, Benjamin C., Zhang, Fang, Jensen, Barbara, Omoyinmi, Ebun, Torrance, Robert, Papadopoulou, Charalampia, Cummins, Michelle, Roderick, Marion, Thrasher, Adrian J., Brogan, Paul A., Eleftheriou, Despina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073084/ https://www.ncbi.nlm.nih.gov/pubmed/35529868 http://dx.doi.org/10.3389/fimmu.2022.852830

Ejemplares similares

Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis
por: Papadopoulou, Charalampia, et al.
Publicado: (2019)

Testicular ischemia in deficiency of adenosine deaminase 2 (DADA2)
por: Clarke, Katherine, et al.
Publicado: (2019)

Adenosine Deaminase (ADA) Level in Tubercular Pleural Effusion
por: Verma, S.K., et al.
Publicado: (2008)

Efficacy and safety of anakinra for undifferentiated autoinflammatory diseases in children: a retrospective case review
por: Garg, Suchika, et al.
Publicado: (2019)

Distinct Roles of Adenosine Deaminase Isoenzymes ADA1 and ADA2: A Pan-Cancer Analysis
por: Gao, Zhao-wei, et al.
Publicado: (2022)

Novel Adenosine Deaminase 2 (ADA2) Mutations Associated With Hematological Manifestations
por: Albalawi, Reem, et al.
Publicado: (2021)

Monogenic polyarteritis nodosa caused by ADA2 Deficiency: the GOSH experience
por: Nanthapisal, S, et al.
Publicado: (2015)

Cutaneous Vasculitis and Digital Ischaemia Caused by Heterozygous Gain-of-Function Mutation in C3
por: Omoyinmi, Ebun, et al.
Publicado: (2018)

Vasculitis in a patient with mevalonate kinase deficiency (MKD): a case report
por: Omoyinmi, Ebun, et al.
Publicado: (2021)

Atypical presentation of adenosine deaminase 2 deficiency with bi‐allelic ADA2 mutation
por: Al‐shaikh, Reem, et al.
Publicado: (2022)

Inhibition of adenosine deaminase (ADA)-mediated metabolism of cordycepin by natural substances
por: Li, Gen, et al.
Publicado: (2015)

Diagnostic Value of Serum Adenosine Deaminase (ADA) Level for Pulmonary Tuberculosis
por: Salmanzadeh, Shokrollah, et al.
Publicado: (2015)

Case report: marfan syndrome (MFS) mimicking cutaneous vasculitis
por: Price-Kuehne, Fiona, et al.
Publicado: (2023)

Polymorphisme de l'adénosine déaminase (ada) dans l'espèce bovine
por: Ansay, M, et al.
Publicado: (1972)

Review of Treatment for Adenosine Deaminase Deficiency (ADA) Severe Combined Immunodeficiency (SCID)
por: Secord, Elizabeth, et al.
Publicado: (2022)

Development and Validation of a Targeted Next-Generation Sequencing Gene Panel for Children With Neuroinflammation
por: McCreary, Dara, et al.
Publicado: (2019)

Janus kinase 1/2 inhibition for the treatment of autoinflammation associated with heterozygous TNFAIP3 mutation
por: Mulhern, Ciara M., et al.
Publicado: (2019)

Novel ADA2 Compound Heterozygous Mutations Resulting in Deficiency of Adenosine Deaminase 2 in a Pair of Siblings
por: Guo, Li, et al.
Publicado: (2021)

Plasma Adenosine Deaminase (ADA)-1 and -2 Demonstrate Robust Ontogeny Across the First Four Months of Human Life
por: Odumade, Oludare A., et al.
Publicado: (2021)

PEGylated Recombinant Adenosine Deaminase Maintains Detoxification and Lymphocyte Counts in Patients with ADA-SCID
por: Dorsey, Morna J., et al.
Publicado: (2023)

A rapid turnaround gene panel for severe autoinflammation: Genetic results within 48 hours
por: McCreary, Dara, et al.
Publicado: (2022)

ELISA based assays to measure adenosine deaminases concentration in serum and saliva for the diagnosis of ADA2 deficiency and cancer
por: Luo, Wenwen, et al.
Publicado: (2022)

Relation of serum adenosine deaminase (ADA) levels with sputum smear conversion in patients with pulmonary tuberculosis
por: Okutan, Oguzhan, et al.
Publicado: (2006)

Correction to: PEGylated Recombinant Adenosine Deaminase Maintains Detoxification and Lymphocyte Counts in Patients with ADA-SCID
por: Dorsey, Morna J., et al.
Publicado: (2023)

A case of Myhre syndrome mimicking juvenile scleroderma
por: Jensen, Barbara, et al.
Publicado: (2020)

Moyamoya-like cerebrovascular disease in a child with a novel mutation in myosin heavy chain 11
por: Keylock, Annette, et al.
Publicado: (2018)

Levels of adenosine deaminase in some experimental animal tumours and the possible therapeutic effect of the ADA inhibitor 2-deoxy-coformycin.
por: Hall, J. G., et al.
Publicado: (1979)

Mitochondrial and oxidative stress genes are differentially expressed in neutrophils of sJIA patients treated with tocilizumab: a pilot microarray study
por: Omoyinmi, Ebun, et al.
Publicado: (2016)

Cutaneous Vasculitis and Recurrent Infection Caused by Deficiency in Complement Factor I
por: Nanthapisal, Sira, et al.
Publicado: (2018)

Use of adenosine deaminase (ADA) to diagnose suspected peritoneal tuberculosis in Rwanda: a cross-sectional study
por: Ntwari, Jules, et al.
Publicado: (2020)

Changes in Adenosine Deaminase Activity in Patients with Type 2 Diabetes Mellitus and Effect of DPP-4 Inhibitor Treatment on ADA Activity
por: Lee, Jae-Geun, et al.
Publicado: (2011)

The ADA*2 allele of the adenosine deaminase gene (20q13.11) and recurrent spontaneous abortions: an age-dependent association
por: Nunes, Daniela Prudente Teixeira, et al.
Publicado: (2011)

Secondary C1q Deficiency in Activated PI3Kδ Syndrome Type 2
por: Hong, Ying, et al.
Publicado: (2019)

OR13-002 Recessive mutations in CECR1, encoding adenosine deaminase 2 (ADA2), cause systemic and cutaneous polyarteritis nodosa (PAN)
por: Levy-Lahad, E, et al.
Publicado: (2013)

Gene hunting in autoinflammation
por: Standing, Ariane, et al.
Publicado: (2013)

Autoinflammation due to homozygous S208 MEFV mutation
por: Hong, Ying, et al.
Publicado: (2019)

Management of severe hyperinflammation in the COVID-19 era: the role of the rheumatologist
por: Papadopoulou, Charalampia, et al.
Publicado: (2020)

Evaluation of the adenosine deaminase (ADA) G22A gene polymorphism with recurrent spontaneous abortion among Egyptian patients
por: Farhan, Hanan Mohamed, et al.
Publicado: (2017)

OR13-001 Loss-of-function mutations in CECR1, encoding adenosine deaminase 2 (ADA2), cause recurrent fevers and early onset strokes
por: Zhou, Q, et al.
Publicado: (2013)

Soluble Ecto-5′-nucleotidase (5′-NT), Alkaline Phosphatase, and Adenosine Deaminase (ADA1) Activities in Neonatal Blood Favor Elevated Extracellular Adenosine
por: Pettengill, Matthew, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_l6iplj57jetkbh3bkmafcaj4g0